These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 12021307)
1. Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. Haque MA; Li P; Jackson SK; Zarour HM; Hawes JW; Phan UT; Maric M; Cresswell P; Blum JS J Exp Med; 2002 May; 195(10):1267-77. PubMed ID: 12021307 [TBL] [Abstract][Full Text] [Related]
2. Reduced immunogenicity of Plasmodium falciparum gamete surface antigen (Pfs48/45) in mice after disruption of disulphide bonds - evaluating effect of interferon-γ-inducible lysosomal thiol reductase. Merino KM; Bansal GP; Kumar N Immunology; 2016 Aug; 148(4):433-47. PubMed ID: 27177843 [TBL] [Abstract][Full Text] [Related]
3. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma. Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048 [TBL] [Abstract][Full Text] [Related]
4. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition. Haque MA; Hawes JW; Blum JS J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711 [TBL] [Abstract][Full Text] [Related]
5. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923 [TBL] [Abstract][Full Text] [Related]
6. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen. Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095 [TBL] [Abstract][Full Text] [Related]
7. Role of APC in the selection of immunodominant T cell epitopes. Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031 [TBL] [Abstract][Full Text] [Related]
8. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. O'Donnell PW; Haque A; Klemsz MJ; Kaplan MH; Blum JS J Immunol; 2004 Jul; 173(2):731-5. PubMed ID: 15240658 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers. Janjic B; Andrade P; Wang XF; Fourcade J; Almunia C; Kudela P; Brufsky A; Jacobs S; Friedland D; Stoller R; Gillet D; Herberman RB; Kirkwood JM; Maillere B; Zarour HM J Immunol; 2006 Aug; 177(4):2717-27. PubMed ID: 16888034 [TBL] [Abstract][Full Text] [Related]
10. Diverse cellular and organismal functions of the lysosomal thiol reductase GILT. Rausch MP; Hastings KT Mol Immunol; 2015 Dec; 68(2 Pt A):124-8. PubMed ID: 26116226 [TBL] [Abstract][Full Text] [Related]
11. MHC class II-restricted presentation of the major house dust mite allergen Der p 1 Is GILT-dependent: implications for allergic asthma. West LC; Grotzke JE; Cresswell P PLoS One; 2013; 8(1):e51343. PubMed ID: 23326313 [TBL] [Abstract][Full Text] [Related]
12. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037 [TBL] [Abstract][Full Text] [Related]
13. Antigen-presenting cells and the selection of immunodominant epitopes. Blum JS; Ma C; Kovats S Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428 [TBL] [Abstract][Full Text] [Related]
14. Defective antigen processing in GILT-free mice. Maric M; Arunachalam B; Phan UT; Dong C; Garrett WS; Cannon KS; Alfonso C; Karlsson L; Flavell RA; Cresswell P Science; 2001 Nov; 294(5545):1361-5. PubMed ID: 11701933 [TBL] [Abstract][Full Text] [Related]
15. DM determines the cryptic and immunodominant fate of T cell epitopes. Nanda NK; Sant AJ J Exp Med; 2000 Sep; 192(6):781-8. PubMed ID: 10993909 [TBL] [Abstract][Full Text] [Related]
16. High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma. Buetow KH; Meador LR; Menon H; Lu YK; Brill J; Cui H; Roe DJ; DiCaudo DJ; Hastings KT J Immunol; 2019 Nov; 203(10):2577-2587. PubMed ID: 31591149 [TBL] [Abstract][Full Text] [Related]
17. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167 [TBL] [Abstract][Full Text] [Related]
18. Role of disulfide bonds in regulating antigen processing and epitope selection. Li P; Haque MA; Blum JS J Immunol; 2002 Sep; 169(5):2444-50. PubMed ID: 12193713 [TBL] [Abstract][Full Text] [Related]
19. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies. Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775 [TBL] [Abstract][Full Text] [Related]
20. B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway. Su Y; Carey G; Maric M; Scott DW J Immunol; 2008 Jul; 181(2):1153-60. PubMed ID: 18606668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]